(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics
 
 
Alternative Scenarios - 3
Blood Banking - 105
Cancer - 92
Clinical Chemistry - 262
Coagulation - 89
Decentralized Testing - 3
DNA Probes/Biochips - 33
Genetic Testing - 1
Hematology/Flow Cytometry - 98
Hemostasis - 70
Histology/Cytology - 2
Immunodiagnostics - 26
Infectious Diseases - 295
Microbiology Testing - 80
Molecular Diagnostics - 141
NAT - 82
POC Testing - 163
Strategic Planning - 24
Top 10 Companies - 22
Transfusion Testing - 84
Tumor Markers - 75
 
 In Vitro Diagnostics Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  2  3  4  5  6  7  8  9  10  11  Next »
Sexually-Transmitted Diseases (STD): Global Market Outlook and Emerging Opportunities

This report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis....

 

$8500.00
       
2023 Opportunities in the Global Immunoprotein Diagnostic
Testing Market


This new report from Venture Planning Group provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

 

$8500.00
       
World Tumor Marker and Special Chemistry Testing Market: Supplier Shares, Competitive Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review

This new report from VPGMarketResearch.com provides analysis of the global tumor markers and special chemistry testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

 

$8500.00
       
Therapeutic Drug Monitoring (TDM): US, Europe (France, Germany, Italy, Spain, UK), Japan--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

This new report from VPGMarketResearch.com provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

 

$8500.00
       
Endocrine Function Market: US, Europe (France, Germany, Italy, Spain, UK), Japan--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

This new report from VPGMarketResearch.com provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers.



 

$8500.00
       
Drugs of Abuse: US, Europe (France, Germany, Italy, Spain, UK), Japan--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts

This new report from VPGMarketResearch.com provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.



 

$8500.00
       
Hematology and Flow Cytometry Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and point-of-care/POC markets during the next five years. The report explores business and technological trends in the US hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers....

 

$8500.00
       
2023 Asia-Pacific Tumor Marker Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

This new 18-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$8500.00
       
2023 Asia-Pacific Hemostasis Diagnostics Market: Reagent and Instrument Sales Forecasts, Volume Projections for 40 Tests, Competitive Strategies, Instrumentation Review, Innovative Technologies, Opportunities for Suppliers

This new 18-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$8500.00
       
Analysis of the Respiratory Disease Testing Market in Europe:
Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis


This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

About this Report

This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK)....


 

$8300.00
       
Infectious Disease Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

“Infectious Disease Testing in the US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.

 

$8200.00
       
Enteric Diseases: Global Market Outlook and Emerging Opportunities

This report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E....

 

$8000.00
       
Analysis of the Sexually-Transmitted Disease Testing Market in Europe: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis

This new 318-page report from Venture Planning Group provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:


 

$7900.00
       
US Hospital Clinical Chemistry and Immunodiagnostics Market Forecasts: Reagent and Instrument Supplier Shares, Competitive Strategies, Innovative Technologies, Instrumentation Review

This new report from VPGMarketResearch.com presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market.

 

$7800.00
       
Siemens: Diagnostics Sales, Market Shares and Competitive Position by Product and Country

This unique market intelligence report from Venture Planning Group provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Siemens and its main competitors, as well as a profile of the company�s diagnostics business.



 

$7500.00
       
2023 European Molecular Blood Typing, Grouping and Infectious Disease NAT Market: France, Germany, Italy, Spain, UK--Emerging Technologies, Sales Forecasts, Supplier Shares, Competitive Strategies

This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.


 

$7500.00
       
2023 Middle East Blood Typing, Grouping and Infectious Disease Screening Market: Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

This new 11-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
2023 North America Blood Typing, Grouping and Infectious Disease Screening Market: Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

This new 3-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test....


 

$7500.00
       
« Previous     2  3  4  5  6  7  8  9  10  11   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X